Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
Clinical trial NCT07437560 · RECRUITING
Trial details
- NCT number
- NCT07437560
- Sponsor
- Hudson Biotech
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2027-02-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.